Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07815106) titled 'OPtimization of Antiplatelet Therapy After the intervenTION of de Novo Coronary Artery Lesions With Drug-Coated Balloons' on Sept. 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Shanghai Zhongshan Hospital

Condition: Chronic Coronary Syndrome

Intervention: Drug: 1-month DAPT

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: October 1, 2026

Target Sample Size: 2122

To know more, visit https://clinicaltrials.gov/study/NCT07815106

Published by H...